Filing Details

Accession Number:
0001387131-18-006984
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-21 20:02:26
Reporting Period:
2018-12-19
Accepted Time:
2018-12-21 20:02:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
25743 Therapeuticsmd Inc. TXMD Pharmaceutical Preparations (2834) 870233535
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1532235 G Robert Finizio 6800 Broken Sound Pkwy Nw, Third Floor
Boca Raton FL 33487
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-12-19 92,000 $0.10 18,458,559 No 4 M Direct
Common Stock Disposition 2018-12-19 92,000 $3.70 18,366,559 No 4 S Direct
Common Stock Acquisiton 2018-12-20 92,910 $0.10 18,459,469 No 4 M Direct
Common Stock Disposition 2018-12-20 92,910 $3.63 18,366,559 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2018-12-19 92,000 $0.00 92,000 $0.10
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2018-12-20 92,910 $0.00 92,910 $0.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
92,910 2012-01-01 2019-01-01 No 4 M Direct
0 2012-01-01 2019-01-01 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,335,136 Indirect See footnote
Common Stock 664,864 Indirect See footnote
Footnotes
  1. The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.59 to $3.875, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.51 to $3.845, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. By the Reporting Person's Grantor-Retained Annuity Trust.
  5. By Robert Finizio Revocable Trust.